Paradigm Shift in the Treatment of Meningiomas.
Classification
Endoscope
Intracranial
Medical imaging
Meningioma
Microscope
Molecular
Neuronavigation
Prevalence
Simpson grade
Spinal
WHO grade
Journal
Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103
Informations de publication
Date de publication:
2023
2023
Historique:
medline:
13
7
2023
pubmed:
11
7
2023
entrez:
11
7
2023
Statut:
ppublish
Résumé
Meningiomas are the most common brain tumor in adults with rising incidence rates due to an aging population globally, increased availability of neuroimaging, and increased awareness of this condition by treating clinicians and primary care physicians. Surgical resection remains the mainstay of treatment, with adjuvant radiotherapy reserved for higher grade meningiomas or tumors that undergo incomplete resections. Whereas these tumors were classically defined by their histopathological features and subtypes, recent work has uncovered the molecular alterations that may lead to tumor development and have important prognostic implications. However, there remain important clinical questions regarding the management of meningiomas and current clinical guidelines continue to evolve as additional studies add onto the growing body of work that enables us to better understand these tumors.
Identifiants
pubmed: 37432615
doi: 10.1007/978-3-031-29750-2_1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-4Informations de copyright
© 2023. Springer Nature Switzerland AG.
Références
Cushing H. The meningiomas (dural endotheliomas): Their source, and favored seats of origin. Brain 1922; 45: 282–316.
doi: 10.1093/brain/45.2.282
Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957; 20: 22–39.
doi: 10.1136/jnnp.20.1.22
pubmed: 13406590
pmcid: 497230
Sicking J, Voss KM, Spille DC, Schipmann S, Holling M, Paulus W et al. The evolution of cranial meningioma surgery-a single-center 25-year experience. Acta Neurochir (Wien) 2018; 160: 1801–1812.
doi: 10.1007/s00701-018-3617-6
pubmed: 29974236
Bailo M, Gagliardi F, Boari N, Castellano A, Spina A, Mortini P. The Role of Surgery in Meningiomas. Curr Treat Options Neurol 2019; 21: 51.
doi: 10.1007/s11940-019-0587-9
pubmed: 31560106
Seifert V. Clinical management of petroclival meningiomas and the eternal quest for preservation of quality of life: personal experiences over a period of 20 years. Acta Neurochir (Wien) 2010; 152: 1099–1116.
doi: 10.1007/s00701-010-0633-6
pubmed: 20419460
Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E et al. EANO guidelines for the diagnosis and treatment of meningiomas. The Lancet Oncology 2016; 17: e383–e391.
doi: 10.1016/S1470-2045(16)30321-7
pubmed: 27599143
Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ. Meningiomas. In Kleihues P, Cavenee WK, eds Pathology and Genetics of Tumours of the Nervous System: World Health Organisation Classification of Tumours Lyon: IARC 2000: 175–184.
Duong LM, McCarthy BJ, McLendon RE, Dolecek TA, Kruchko C, Douglas LL et al. Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004–2007. Cancer 2012; 118: 4220–4227.
doi: 10.1002/cncr.27390
pubmed: 22907705
Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol 2001; 3: 152–158.
pubmed: 11465395
pmcid: 1920611
Porter KR, McCarthy BJ, Freels S, Kim Y, Davis FG. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol 2010; 12: 520–527.
doi: 10.1093/neuonc/nop066
pubmed: 20511189
pmcid: 2940648
Elia-Pasquet S, Provost D, Jaffre A, Loiseau H, Vital A, Kantor G et al. Incidence of central nervous system tumors in Gironde, France Neuroepidemiology 2004; 23: 110–117.
doi: 10.1159/000075953
pubmed: 15084779
Holleczek B, Zampella D, Urbschat S, Sahm F, von Deimling A, Oertel J et al. Incidence, mortality and outcome of meningiomas: A population-based study from Germany. Cancer Epidemiol 2019; 62: 101562.
doi: 10.1016/j.canep.2019.07.001
pubmed: 31325769
Marosi C, Hassler M, Roessler K, Reni M, Sant M, Mazza E et al. Meningioma. Crit Rev Oncol Hematol 2008; 67: 153–171.
doi: 10.1016/j.critrevonc.2008.01.010
pubmed: 18342535
Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol 2010; 99: 307–314.
doi: 10.1007/s11060-010-0386-3
pubmed: 20821343
pmcid: 2945461
Cea-Soriano L, Wallander MA, Garcia Rodriguez LA. Epidemiology of meningioma in the United Kingdom. Neuroepidemiology 2012; 39: 27–34.
doi: 10.1159/000338081
pubmed: 22777495
Sun T, Plutynski A, Ward S, Rubin JB. An integrative view on sex differences in brain tumors. Cell Mol Life Sci 2015; 72: 3323–3342.
doi: 10.1007/s00018-015-1930-2
pubmed: 25985759
pmcid: 4531141
Morris Z, Whiteley WN, Longstreth WT, Jr., Weber F, Lee YC, Tsushima Y et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2009; 339: b3016.
doi: 10.1136/bmj.b3016
pubmed: 19687093
pmcid: 2728201
Hayward R. VOMIT (victims of modern imaging technology)—an acronym for our times. BMJ 2003; 326: 1273.
doi: 10.1136/bmj.326.7401.1273
pmcid: 1126156
de Boer AW, Drewes YM, de Mutsert R, Numans ME, den Heijer M, Dekkers OM et al. Incidental findings in research: A focus group study about the perspective of the research participant. J Magn Reson Imaging 2018; 47: 230–237.
doi: 10.1002/jmri.25739
pubmed: 28470774
Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM et al. Molecular and translational advances in meningiomas. Neuro Oncol 2019; 21: i4–i17.
doi: 10.1093/neuonc/noy178
pubmed: 30649490
pmcid: 6347079
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016; 131: 803–820.
doi: 10.1007/s00401-016-1545-1
pubmed: 27157931
Bi WL, Abedalthagafi M, Horowitz P, Agarwalla PK, Mei Y, Aizer AA et al. Genomic landscape of intracranial meningiomas. J Neurosurg 2016; 125: 525–535.
doi: 10.3171/2015.6.JNS15591
pubmed: 26771848
Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S et al. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 2017; 18: 682–694.
doi: 10.1016/S1470-2045(17)30155-9
pubmed: 28314689
Karsy M, Azab MA, Abou-Al-Shaar H, Guan J, Eli I, Jensen RL et al. Clinical potential of meningioma genomic insights: a practical review for neurosurgeons. Neurosurg Focus 2018; 44: E10.
doi: 10.3171/2018.2.FOCUS1849
pubmed: 29852774
Sughrue ME, Kane AJ, Shangari G, Rutkowski MJ, McDermott MW, Berger MS et al. The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg 2010; 113: 1029–1035.
doi: 10.3171/2010.3.JNS091971
pubmed: 20380529
Gezen F, Kahraman S, Canakci Z, Beduk A. Review of 36 cases of spinal cord meningioma. Spine (Phila Pa 1976) 2000; 25: 727–731.
doi: 10.1097/00007632-200003150-00013
pubmed: 10752106
Klekamp J, Samii M. Surgical results of spinal meningiomas. Acta Neurochir Suppl 1996; 65: 77–81.
pubmed: 8738502
Nakamura M, Tsuji O, Fujiyoshi K, Hosogane N, Watanabe K, Tsuji T et al. Long-term surgical outcomes of spinal meningiomas. Spine (Phila Pa 1976) 2012; 37: E617–623.
doi: 10.1097/BRS.0b013e31824167f1
pubmed: 22146282
Tsuda K, Akutsu H, Yamamoto T, Nakai K, Ishikawa E, Matsumura A. Is Simpson grade I removal necessary in all cases of spinal meningioma? Assessment of postoperative recurrence during long-term follow-up. Neurol Med Chir (Tokyo) 2014; 54: 907–913.
doi: 10.2176/nmc.oa.2013-0311
pubmed: 24759095
Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 2013; 339: 1077–1080.
doi: 10.1126/science.1233009
pubmed: 23348505
pmcid: 4808587
Clark VE, Harmanci AS, Bai H, Youngblood MW, Lee TI, Baranoski JF et al. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat Genet 2016; 48: 1253–1259.
doi: 10.1038/ng.3651
pubmed: 27548314
pmcid: 5114141